Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Open-labeled, Parallel -Controlled Clinical Study Investigating Huaier Granule for Prevention of Disease Progression of Hepatocarcinoma After Non-radical Hepatectomy

NCT01760616 is registered in ClinicalTrials.gov with Qidong Gaitianli Medicines Co., Ltd as lead sponsor.

NCT NCT01760616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01760616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Open-labeled, Parallel -Controlled Clinical Study Investigating Huaier Granule for Prevention of Disease Progression of Hepatocarcinoma After Non-radical Hepatectomy
Lead sponsor
Qidong Gaitianli Medicines Co., Ltd
Phase
Phase 4
Overall status
Terminated
Start date
November 7, 2011
Completion date
June 30, 2017
Enrollment
790 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic carcinoma